241 related articles for article (PubMed ID: 25843662)
1. Novel curcumin-based pyrano[2,3-d]pyrimidine anti-oxidant inhibitors for α-amylase and α-glucosidase: Implications for their pleiotropic effects against diabetes complications.
Yousefi A; Yousefi R; Panahi F; Sarikhani S; Zolghadr AR; Bahaoddini A; Khalafi-Nezhad A
Int J Biol Macromol; 2015; 78():46-55. PubMed ID: 25843662
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant and glycohydrolase inhibitory behavior of curcumin-based compounds: Synthesis and evaluation of anti-diabetic properties in vitro.
Mehrabi M; Esmaeili S; Ezati M; Abassi M; Rasouli H; Nazari D; Adibi H; Khodarahmi R
Bioorg Chem; 2021 May; 110():104720. PubMed ID: 33662896
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of new curcumin derivatives as influential antidiabetic α-glucosidase and α-amylase inhibitors with anti-oxidant activity.
Tavaf Z; Dangolani SK; Yousefi R; Panahi F; Shahsavani MB; Khalafi-Nezhad A
Carbohydr Res; 2020 Aug; 494():108069. PubMed ID: 32563890
[TBL] [Abstract][Full Text] [Related]
4. Curcumin-based Antioxidant and Glycohydrolase Inhibitor Compounds: Synthesis and In Vitro Appraisal of the Dual Activity Against Diabetes.
Esmaeili S; Ghobadi N; Nazari D; Pourhossein A; Rasouli H; Adibi H; Khodarahmi R
Med Chem; 2021; 17(7):677-698. PubMed ID: 32370719
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, spectroscopic characterizations, antidiabetic, in silico and kinetic evaluation of novel curcumin-fused aldohexoses.
Ezati M; Ghavamipour F; Adibi H; Pouraghajan K; Arab SS; Sajedi RH; Khodarahmi R
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jan; 285():121806. PubMed ID: 36108405
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel poly-hydroxyl functionalized acridine derivatives as inhibitors of α-Glucosidase and α-Amylase.
Toobaei Z; Yousefi R; Panahi F; Shahidpour S; Nourisefat M; Doroodmand MM; Khalafi-Nezhad A
Carbohydr Res; 2015 Jun; 411():22-32. PubMed ID: 25957572
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of β-Ketoamide Curcumin Analogs for Anti-Diabetic and AGEs Inhibitory Activities.
Banuppriya G; Sribalan R; Fathima SAR; Padmini V
Chem Biodivers; 2018 Aug; 15(8):e1800105. PubMed ID: 29752771
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new pyrimidine-fused derivatives as potent and selective antidiabetic α-glucosidase inhibitors.
Panahi F; Yousefi R; Mehraban MH; Khalafi-Nezhad A
Carbohydr Res; 2013 Oct; 380():81-91. PubMed ID: 23978663
[TBL] [Abstract][Full Text] [Related]
9. Synthesis,
Ezati M; Ghavamipour F; Hassan Yazdi MM; Sadrjavadi K; H Sajedi R; Adibi H; Khodarahmi R
J Biomol Struct Dyn; 2023; 41(22):12686-12702. PubMed ID: 36755431
[TBL] [Abstract][Full Text] [Related]
10. Turmeric (Curcuma longa L.) volatile oil inhibits key enzymes linked to type 2 diabetes.
Lekshmi PC; Arimboor R; Indulekha PS; Menon AN
Int J Food Sci Nutr; 2012 Nov; 63(7):832-4. PubMed ID: 22385048
[TBL] [Abstract][Full Text] [Related]
11. The assessment of antidiabetic properties of novel synthetic curcumin analogues: α-amylase and α-glucosidase as the target enzymes.
Hasaninezhad F; Tavaf Z; Panahi F; Nourisefat M; Khalafi-Nezhad A; Yousefi R
J Diabetes Metab Disord; 2020 Dec; 19(2):1505-1515. PubMed ID: 33553036
[TBL] [Abstract][Full Text] [Related]
12. Studies on the potential antioxidant properties of Senecio stabianus Lacaita (Asteraceae) and its inhibitory activity against carbohydrate-hydrolysing enzymes.
Tundis R; Menichini F; Loizzo MR; Bonesi M; Solimene U; Menichini F
Nat Prod Res; 2012; 26(5):393-404. PubMed ID: 21644170
[TBL] [Abstract][Full Text] [Related]
13. Turmerin, the antioxidant protein from turmeric (Curcuma longa) exhibits antihyperglycaemic effects.
Lekshmi PC; Arimboor R; Raghu KG; Menon AN
Nat Prod Res; 2012; 26(17):1654-8. PubMed ID: 21972920
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Potential Antidiabetic Properties of Curcumin-Based Derivatives: An
Ezati M; Ghavamipour F; Khosravi N; Sajedi RH; Chalabi M; Farokhi A; Adibi H; Khodarahmi R
Med Chem; 2022; 19(1):99-117. PubMed ID: 35579152
[TBL] [Abstract][Full Text] [Related]
15. Pyrimidine-fused heterocycle derivatives as a novel class of inhibitors for α-glucosidase.
Yousefi R; Alavian-Mehr MM; Mokhtari F; Panahi F; Mehraban MH; Khalafi-Nezhad A
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1228-35. PubMed ID: 23043430
[TBL] [Abstract][Full Text] [Related]
16. Alpha-glucosidase inhibition of natural curcuminoids and curcumin analogs.
Du ZY; Liu RR; Shao WY; Mao XP; Ma L; Gu LQ; Huang ZS; Chan AS
Eur J Med Chem; 2006 Feb; 41(2):213-8. PubMed ID: 16387392
[TBL] [Abstract][Full Text] [Related]
17. Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico.
Jhong CH; Riyaphan J; Lin SH; Chia YC; Weng CF
Biofactors; 2015; 41(4):242-51. PubMed ID: 26154585
[TBL] [Abstract][Full Text] [Related]
18. Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean.
McCue P; Kwon YI; Shetty K
Asia Pac J Clin Nutr; 2005; 14(2):145-52. PubMed ID: 15927931
[TBL] [Abstract][Full Text] [Related]
19. Differential α-amylase/α-glucosidase inhibitory activities of plant-derived phenolic compounds: a virtual screening perspective for the treatment of obesity and diabetes.
Rasouli H; Hosseini-Ghazvini SM; Adibi H; Khodarahmi R
Food Funct; 2017 May; 8(5):1942-1954. PubMed ID: 28470323
[TBL] [Abstract][Full Text] [Related]
20. Caffeic and chlorogenic acids inhibit key enzymes linked to type 2 diabetes (in vitro): a comparative study.
Oboh G; Agunloye OM; Adefegha SA; Akinyemi AJ; Ademiluyi AO
J Basic Clin Physiol Pharmacol; 2015 Mar; 26(2):165-70. PubMed ID: 24825096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
